DOI: 10.1055/s-00023610

Drug Research

Ausgabe 02 · Volume 66 · Februar 2016 DOI: 10.1055/s-006-30995

Opinion Paper

57
Wehling, M.: How to Use the FORTA (“Fit fOR The Aged”) List to Improve Pharmacotherapy in the Elderly

Original Article

63
Qiao, D.-D.; Mi, G.-L.; Tang, M.-Q.: Tricyclic Neovibsanin Scaffold (TCNS) as an Effective Antidepressant Agent
69
Ludwig, S.; Stier, H.; Weykam, S.: Evaluation of Blood Alcohol Concentrations after Oral Administration of a Fixed Combination of Thyme Herb and Primrose Root Fluid Extract to Children with Acute Bronchitis
74
Kasahara, N.; Fukase, H.; Ohba, Y.; Saito, T.; Miyata, K.; Iida, S.; Takano, Y.; Ikeda, S.; Harigai, M.; Terao, K.: A Pharmacokinetic/Pharmacodynamic Drug–Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs
Supporting Information
82
Srinivas, N. R.: Limited Sampling Strategy for the Prediction of Area Under the Curve (AUC) of Statins: Reliability of a Single Time Point for AUC Prediction for Pravastatin and Simvastatin
94
Tani, S.; Nagao, K.; Hirayama, A.: Differences between Mitiglinide/Voglibose Fixed-dose Combination and Glimepiride in Modifying Low-density Lipoprotein Heterogeneity in Japanese Type-2 Diabetic Patients: A Pilot Study
100
Xin, X.; Wu, Y.; Liu, X.; Sun, C.; Geng, T.; Ding, L.: Pharmacokinetics of Oral Combination Contraceptive Drugs Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Chinese Volunteers
107
Jain, M. R.; Joharapurkar, A. A.; Pandya, V.; Patel, V.; Joshi, J.; Kshirsagar, S.; Patel, K.; Patel, P. R.; Desai, R. C.: Pharmacological Characterization of ZYAN1, a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia